For those in the medical profession, you’ll realise that migraines are one disorder that we ourselves suffer a great deal – and if you’ve had one, you’ll develop a great deal of empathy very quickly for your patients. The American Academy of Neurology has reviewed the evidence and provided some great recommendations in a short guideline update in regards to the best pharmacopreventive strategy.
Grade A recommendations include valproate, topiramate, divalproex sodium, metoprolol, propranolol (and possibly timolol – no new evidence), as well as frovatriptan.
For the full breakdown and some guided commentary, check out the article here. An accompanying article on NSAIDs and other complementary therapies has been included in the resources section.
The guideline is here.
source | AAN
image | zigazou76